Search
Anika Therapeutics Inc
ANIKAdd to Watchlist
19.250USD
+1.180+6.53%
Close 07-31 16:00（ET）Quotes delayed by 15 min
257.12MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Anika Therapeutics Inc is 9.00, ranking 4 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 16.00, with a high of 16.00 and a low of 16.00.
Analyst Rating
Based on
2
analysts
Strong Buy
Current Rating
19.000
Target Price
+17.50%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Anika Therapeutics Inc
ANIK
2
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
31
Stryker Corp
SYK
30
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Anika Therapeutics Inc's expected revenue for the next quarter?
Anika Therapeutics Inc's expected revenue is 29.74M.
What is Anika Therapeutics Inc's price target?
Analysts forecast that Anika Therapeutics Inc's price target is USD 16.00, with the highest forecast at USD 16.00 and the lowest forecast at USD 16.00.
How have Anika Therapeutics IncANIK's recent earnings per share performed?
The market expectation was USD 0.25, while Anika Therapeutics IncANIK's earnings per share (EPS) for the previous quarter was USD -0.37. EPS for the next quarter is expected at USD 0.04.
What is the analyst rating for Anika Therapeutics Inc?
Based on the ratings of Anika Therapeutics Inc's stock from 2 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.